Dental Caries in Children

2
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

ADvantage Therapeutics
3 programs
2
38% silver diamine fluoridePhase 21 trial
Test varnishPhase 21 trial
Silver Diamine Fluoride/Sodium Fluoride VarnishN/A1 trial
Active Trials
NCT05395065CompletedEst. Jan 2024
NCT05670743CompletedEst. Aug 2024
NCT04947527CompletedEst. Aug 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
ADvantage Therapeutics38% silver diamine fluoride
ADvantage TherapeuticsTest varnish
ADvantage TherapeuticsSilver Diamine Fluoride/Sodium Fluoride Varnish

Clinical Trials (3)

NCT05670743ADvantage Therapeutics38% silver diamine fluoride

Pharmacokinetics of Advantage Arrest in Healthy Children 13-Months to 13-Years of Age

Start: Mar 2023Est. completion: Aug 2024
Phase 2Completed
NCT04947527ADvantage TherapeuticsTest varnish

Efficacy and Safety Evaluation of Anti-Caries Varnish

Start: Jun 2022Est. completion: Aug 2024
Phase 2Completed
NCT05395065ADvantage TherapeuticsSilver Diamine Fluoride/Sodium Fluoride Varnish

Silver Diamine Fluoride Gel: Case Series

Start: Jul 2022Est. completion: Jan 2024
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space